Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 259 | N/A |
| Receivables | 994 | N/A |
| Inventories | 357 | N/A |
| TOTAL | $2,055 | $N/A |
| Non-Current Assets | ||
| PPE Net | 928 | N/A |
| Other Non-Current Assets | 690 | 0 |
| TOTAL | $1,618 | $N/A |
| Total Assets | $3,673 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 319 | N/A |
| Accounts payable and accrued liabilities | 100 | 0 |
| Accrued Expenses | 271 | N/A |
| TOTAL | $27,301 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 259 | N/A |
| TOTAL | $259 | $N/A |
| Total Liabilities | $27,560 | $N/A |
| Shareholders' Equity | ||
| Other shareholders' equity | -23,887 | 0 |
| TOTAL | $-23,887 | $N/A |
| Total Liabilities And Equity | $3,673 | $0 |